Rendering

Component: (Network and Table)
Network
2313301 - Disclosure - Stock-based Compensation (Tables)
(http://www.aeriepharma.com/role/StockBasedCompensationTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001337553 (http://www.sec.gov/CIK)
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
 
Stock-Based Compensation Expense for Options Granted and Restricted Stock as Reflected in the Statement of Operations
Stock-based compensation expense for options granted, RSAs, and stock purchase rights are reflected in the consolidated statements of operations as follows:
 
 
YEAR ENDED DECEMBER 31,
(in thousands)
2016
 
2015
 
2014
Research and development
$
3,781

 
$
2,500

 
$
1,339

General and administrative
13,013

 
10,445

 
7,839

Total
$
16,794

 
$
12,945

 
$
9,178

  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
Key weighted average assumptions utilized in the fair value calculation for the underlying common stock as of December 31, 2016, 2015 and 2014 appear on the table below.
 
 
YEAR ENDED
DECEMBER 31,
 
2016
 
2015
 
2014
Expected term (years)
5.99

 
6.07

 
6.25

Expected stock price volatility
83.94
%
 
74.11
%
 
80.44
%
Risk-free interest rate
1.43
%
 
1.63
%
 
1.90
%
Dividend yield
—
%
 
—
%
 
—
%
  
Schedule of Stock Options Activity
The following table summarizes the stock option activity under the Plans:
 
NUMBER OF
SHARES
 
WEIGHTED AVERAGE
EXERCISE PRICE
 
WEIGHTED
AVERAGE
REMAINING
CONTRACTUAL
LIFE (YEARS)
 
AGGREGATE
INTRINSIC
VALUE
(000’s)
Options outstanding at December 31, 2015
4,583,586

 
$
12.86

 
 
 
 
Granted
993,836

 
20.51

 
 
 
 
Exercised
(166,295
)
 
5.71

 
 
 
 
Canceled
(155,197
)
 
19.33

 
 
 
 
Options outstanding at December 31, 2016
5,255,930

 
$
14.34

 
7.4
 
$
123,649

Options vested or expected to vest(1)
5,198,266

 
$
14.25

 
7.4
 
$
122,751

Options exercisable at December 31, 2016
3,276,694

 
$
10.77

 
6.8
 
$
88,745


(1) Includes vested options and options that are expected to vest in the future after applying an estimated annual forfeiture rate.
  
Schedule of Stock Options Outstanding and Exercisable Option Plans
The following table provides additional information about stock options that are outstanding and exercisable at December 31, 2016:
 
EXERCISE
PRICE
 
OPTIONS
OUTSTANDING
 
WEIGHTED
AVERAGE
REMAINING
CONTRACTUAL
LIFE (YEARS)
 
OPTIONS
EXERCISABLE
 
 
 
 
 
 
 
$0.20 - $3.15
 
2,116,127

 
6.2
 
1,898,863

$10.44 - $15.97
 
419,188

 
8.9
 
105,380

$16.05 - $21.08
 
1,590,359

 
8.0
 
845,903

$22.31 - $26.76
 
317,781

 
8.3
 
125,372

$26.77 - $40.91
 
812,475

 
8.6
 
301,176

 
 
5,255,930

 
 
 
3,276,694

  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes the RSA activity under the Plans:
 
 
NUMBER OF
SHARES
 
WEIGHTED AVERAGE
FAIR VALUE PER SHARE
 
 
 
 
RSAs outstanding at December 31, 2015
119,993

 
$
20.31

Granted
112,655

 
15.98

Vested
(62,905
)
 
13.71

Canceled
(5,549
)
 
20.04

RSAs outstanding at December 31, 2016
164,194

 
$
19.87